Ariad CEO to retire in deal with activist Sarissa
April 29, 2015 at 06:47 AM EDT
Ariad Pharmaceuticals CEO will retire this year in a settlement with hedge fund Sarissa Capital, capping months of agitating at the cancer drug maker.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.